European equities traded in the US as American depositary receipts were tracking lower late Thursday morning, declining 0.47% to 1,438.05 on the S&P Europe Select ADR Index. From continental Europe, ...

Trinity Capital Inc.  (the "Company"), a leading international alternative asset manager, today announced that its Board of Directors declared a cash dividend of $0.51 per share with respect to the ...

Trinity Biotech (TRIB) received notice from the Nasdaq Stock Market LLC that the company is not in compliance with Nasdaq Listing Rule ...

Trinity Biotech, a commercial-stage biotech company focused on human diagnostics and diabetes management solutions, including wearable biosensors, has appointed Barclays Capital as its exclusive finan ...

Trinity Biotech (Nasdaq:TRIB) today announced the next stage of its transformation plan as it looks to bring a CGM to market.

Trinity Biotech (TRIB) announces the next stage in realizing its comprehensive transformation plan and development of its continuous glucose ...

Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announces the next ...

StockNews.com cut shares of Trinity Biotech (NASDAQ:TRIB – Free Report) from a hold rating to a sell rating in a research report released on Thursday. Trinity Biotech Stock Up 1.6 % Shares of TRIB ...

Trinity Capital's dividend yield exceeds 12%, with a payout ratio close to 100%. Read more to see why I'm bullish on TRIN stock.

However, over the past two decades, the country has also invested in building a competitive biotechnology sector. Given its limited domestic market but strong infrastructure in manufacturing, research ...